PGIVAC 2025 Concludes with Day 5 Spotlight on Latest Vaccine Innovations and Public Health Strategies
PGIVAC 2025 Concludes with Day 5 Spotlight on Latest Vaccine Innovations and Public Health Strategies Chandigarh, June 13 – The final day of the PGIVAC 2025 summit concluded with a powerful focus on the theme “Update on Current and New Vaccines,” offering an in-depth review of the latest vaccine science, innovations, and public health strategies across all age groups. The day began with a thought-provoking plenary by Dr. Chandrakant Lahariya, who advocated a life-course approach to immunization, underscoring the importance of vaccine protection from infancy through old age. Dr. Suneela Garg followed with an urgent appeal to strengthen adult immunization strategies in India, while Dr. Kamini Walia drew a crucial connection between vaccination and the fight against antimicrobial resistance. Adding to the practical aspect of adult immunization, Dr. Lalit Sankhe and Dr. Muralidhar Tambe shared valuable insights from operational adult vaccination clinics. Dr. Veena Kamath presented the latest updates on adult pneumococcal vaccines, and a trio of experts—Dr. Parvinder Kaur Chawla, Dr. Ashish Bhalla, and Dr. Rashmi Bagga—reviewed advancements in vaccines for shingles, meningococcal disease, cholera, hepatitis A, HPV, and tuberculosis. Dr. Swayampragyan Parida concluded the pre-lunch session with updates on travel vaccines. Read also: Global Strategies for Strengthening National Immunization The afternoon shifted focus to pediatric immunization, with Dr. Sanjay Verma and Dr. Unmesh Upadhyay discussing licensed childhood and adolescent vaccines, including pneumococcal, hexavalent, typhoid, and RSV vaccines. In subsequent sessions, Dr. Omesh Bharti, Dr. Harpreet Singh, and Dr. Jerome Kim presented vital updates on vaccines targeting rabies, dengue, malaria, and HIV/AIDS. Dr. Vivek Sagar highlighted new research on the Group A Streptococcus vaccine, and Dr. Ravindra Khaiwal addressed the intersection of climate change and immunization delivery. The final technical session, led by Dr. Tarun Saluja, focused on the potential of public-private partnerships to accelerate vaccine research and development, especially in low- and middle-income countries. The day concluded with a valedictory session where Dr. Sanjay Jain, Dean of Research at PGIMER, presented course completion certificates to all PGIVAC participants. With the successful culmination of its five-day agenda, PGIVAC 2025 reaffirmed its status as a leading platform for advancing global vaccine knowledge and nurturing the next generation of vaccinologists and public health champions.